Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study.
about
Leptin, adiponectin, and heart rate variability among police officersAssociation between risk factors for vascular dementia and adiponectin.Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines.Circulating adiponectin levels and risk of type 2 diabetes in the Japanese.Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitusCysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase.Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study.Effect of therapeutic dose of vitamin d on serum adiponectin and glycemia in vitamin d-insufficient or deficient type 2 diabetic patients.High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjectsAdiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study.Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents.Adiponectin, type 2 diabetes and cardiovascular risk.Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis.Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.Effects of pinitol on glycemic control, insulin resistance and adipocytokine levels in patients with type 2 diabetes mellitus.
P2860
Q23917164-60142929-69A7-4EA4-B369-7534C87623ACQ33594133-61E09201-44E3-44F2-8686-A58B8747ABC4Q33628222-003E60AD-121F-4FAA-97E3-920128EE6C22Q34117330-5E353CB1-B34D-4D6C-9839-EEF3D9E57BEAQ34256560-ACEE7139-A3CB-4D53-A797-FAF445374FF6Q34395177-D28E7C5E-82CC-41CE-9C0F-09AB09A70B36Q34517195-AF5AD2C1-0622-49D4-8E88-05C7EFEAEA70Q34733598-55DD252C-9D0A-4C16-AC93-183499AFE8FFQ35688347-837370EA-1508-48DA-A660-CDC4EB15D645Q36426822-2BFBE765-DF4C-44F6-9CDD-6C005A95F3D6Q39017257-95E9AB9A-F4CD-4385-B449-60C9EB56FC6CQ44240418-90B90E2E-5903-445C-9AA5-A6A788CB9918Q49438496-06EE1902-FA02-4DB2-9EBD-61474B04D2C5Q51280278-E3A80ADD-00D3-4DE5-A2D3-426446CB3C07Q51363786-6B31F21B-3677-4AEB-979A-5C06DBCA76B9
P2860
Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Low serum adiponectin predicts ...... lammation: Whitehall II study.
@en
Low serum adiponectin predicts ...... lammation: Whitehall II study.
@nl
type
label
Low serum adiponectin predicts ...... lammation: Whitehall II study.
@en
Low serum adiponectin predicts ...... lammation: Whitehall II study.
@nl
prefLabel
Low serum adiponectin predicts ...... lammation: Whitehall II study.
@en
Low serum adiponectin predicts ...... lammation: Whitehall II study.
@nl
P2093
P2860
P50
P921
P356
P1476
Low serum adiponectin predicts ...... flammation: Whitehall II study
@en
P2093
E J Brunner
P G McTernan
P2860
P304
P356
10.1055/S-0029-1216359
P577
2009-04-15T00:00:00Z